Skip to main content
SpringerLink
Log in

Attention Deficit/Hyperactivity Disorder (ADHD)

  • Chapter
  • First Online:
Mental Health in the Athlete

Abstract

Athletes have rates of ADHD similar or greater than the general population. It is important for the physician treating athletes to recognize ADHD symptoms and to be able to diagnose or refer for diagnosis of the condition and to monitor for adequacy of treatment, presence of side effects, and potential consequences of treatment with medications, including toxicities, medical risk, and the legal status of the medications within the competitive arena. Physical activity helps with symptoms, but may not be sufficient treatment alone for ADHD. Many of the perceived ergogenic effects of stimulant use in elite athletes have not been proven, yet the medications are subject to abuse based on their perceived value. The medical toxicities of cardiac arrhythmias and risk of heat injury are widely cited, but largely unfounded or unproven.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pennington BF, Ozonoff S. Executive functions and developmental psychopathology. J Child Psychol Psychiatry. 1996;37(1):51–87.

    PubMed  Google Scholar 

  2. Pliszka S, Issues AWGoQ. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894–921.

    PubMed  Google Scholar 

  3. Morrow RL, Garland EJ, Wright JM, Maclure M, Taylor S, Dormuth CR. Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children. CMAJ. 2012;184(7):755–62.

    PubMed  PubMed Central  Google Scholar 

  4. Layton TJ, Barnett ML, Hicks TR, Jena AB. Attention deficit-hyperactivity disorder and month of school enrollment. N Engl J Med. 2018;379(22):2122–30.

    PubMed  PubMed Central  Google Scholar 

  5. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD). NIH Consens Statement. 1998;16(2):1–37.

    Google Scholar 

  6. Diagnostic and statistical manual of mental disorders: DSM-5. Arlington, VA: American Psychiatric Association; 2013.

    Google Scholar 

  7. Faraone SV, Perlis RH, Doyle AE, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57(11):1313–23.

    PubMed  Google Scholar 

  8. Cdc. Facts | ADHD | NCBDDD | CDC. 2018.

    Google Scholar 

  9. Centers for Disease Control and Prevention. Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children – United States, 2003 and 2007. MMWR Morb Mortal Wkly Rep. 2010;59(44):1439–43.

    Google Scholar 

  10. Center OSUWM. Athletes with ADHD more likely to choose team sports, could increase injury risk, study finds. 2019.; http://www.sciencedaily.com/releases/2017/05/170511135755.htm. Accessed January 15, 2019.

  11. White RD, Harris GD, Gibson ME. Attention deficit hyperactivity disorder and athletes. Sports Health. 2014;6(2):149–56.

    PubMed  PubMed Central  Google Scholar 

  12. Larson K, Russ SA, Kahn RS, Halfon N. Patterns of comorbidity, functioning, and service use for US children with ADHD, 2007. Pediatrics. 2011;127(3):462–70.

    PubMed  PubMed Central  Google Scholar 

  13. Hamed AM, Kauer AJ, Stevens HE. Why the diagnosis of attention deficit hyperactivity disorder matters. Front Psych. 2015;6:168.

    Google Scholar 

  14. Psychological issues related to illness and injury in athletes and the team physician: a consensus statement-2016 update. Med Sci Sports Exerc. 2017;49(5):1043–54.

    Google Scholar 

  15. Putukian M, Kreher JB, Coppel DB, Glazer JL, McKeag DB, White RD. Attention deficit hyperactivity disorder and the athlete: an American Medical Society for Sports Medicine position statement. Clin J Sport Med. 2011;21(5):392–401.

    PubMed  Google Scholar 

  16. Agency WA-D. Medical Information to Support the Decisions of TUECS – ADHD. 2017. Located at: Medical Information to Support the Decisions of TUECs.

    Google Scholar 

  17. NCAA. NCAA Banned Drugs and Medical Exceptions Policy Guidelines Regarding Medical Reporting for Student-Athletes with Attention Deficit Hyperactivity Disorder (ADHD) Taking Prescribed Stimulants; 2009.

    Google Scholar 

  18. Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5):1007–22.

    Google Scholar 

  19. Reardon CL, Factor RM. Considerations in the use of stimulants in sport. Sports Med. 2016;46(5):611–7.

    PubMed  Google Scholar 

  20. Jensen PS, Hinshaw SP, Swanson JM, et al. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr. 2001;22(1):60–73.

    PubMed  Google Scholar 

  21. Stewman CG, Liebman C, Fink L, Sandella B. Attention deficit hyperactivity disorder: unique considerations in athletes. Sports Health. 2018;10(1):40–6.

    PubMed  Google Scholar 

  22. Vetter VL, Elia J, Erickson C, et al. Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder. Circulation. 2008;117(18):2407–23.

    PubMed  Google Scholar 

  23. Perrin JM, Friedman RA, Knilans TK, Black Box Working Group, Section on Cardiology and Cardiac Surgery. Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder. Pediatrics. 2008;122(2):451–3.

    PubMed  Google Scholar 

  24. Cooper WO, Habel LA, Sox CM, et al. ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med. 2011;365(20):1896–904.

    PubMed  PubMed Central  Google Scholar 

  25. Hailpern SM, Egan BM, Lewis KD, et al. Blood pressure, heart rate, and CNS stimulant medication use in children with and without ADHD: analysis of NHANES data. Front Pediatr. 2014;2:100.

    PubMed  PubMed Central  Google Scholar 

  26. Roelands B, Hasegawa H, Watson P, et al. The effects of acute dopamine reuptake inhibition on performance. Med Sci Sports Exerc. 2008;40(5):879–85.

    PubMed  Google Scholar 

  27. Elbin RJ, Kontos AP, Kegel N, Johnson E, Burkhart S, Schatz P. Individual and combined effects of LD and ADHD on computerized neurocognitive concussion test performance: evidence for separate norms. Arch Clin Neuropsychol. 2013;28(5):476–84.

    PubMed  Google Scholar 

  28. Nelson LD, Guskiewicz KM, Marshall SW, et al. Multiple self-reported concussions are more prevalent in athletes with ADHD and learning disability. Clin J Sport Med. 2016;26(2):120–7.

    PubMed  PubMed Central  Google Scholar 

  29. Iverson GL, Gardner AJ, Terry DP, et al. Predictors of clinical recovery from concussion: a systematic review. Br J Sports Med. 2017;51(12):941–8.

    PubMed  PubMed Central  Google Scholar 

  30. Mautner K, Sussman WI, Axtman M, Al-Farsi Y, Al-Adawi S. Relationship of attention deficit hyperactivity disorder and postconcussion recovery in youth athletes. Clin J Sport Med. 2015;25(4):355–60.

    PubMed  Google Scholar 

  31. Bouchard R, Weber AR, Geiger JD. Informed decision-making on sympathomimetic use in sport and health. Clin J Sport Med. 2002;12(4):209–24.

    PubMed  Google Scholar 

  32. Chandler JV, Blair SN. The effect of amphetamines on selected physiological components related to athletic success. Med Sci Sports Exerc. 1980;12(1):65–9.

    PubMed  Google Scholar 

  33. Conant-Norville DO, Tofler IR. Attention deficit/hyperactivity disorder and psychopharmacologic treatments in the athlete. Clin Sports Med. 2005;24(4):829–43, viii.

    PubMed  Google Scholar 

  34. Liddle DG, Connor DJ. Nutritional supplements and ergogenic AIDS. Prim Care. 2013;40(2):487–505.

    PubMed  Google Scholar 

  35. Yoo JH, Oh Y, Jang B, et al. The effects of equine-assisted activities and therapy on resting-state brain function in attention-deficit/hyperactivity disorder: a pilot study. Clin Psychopharmacol Neurosci. 2016;14(4):357–64.

    PubMed  PubMed Central  Google Scholar 

  36. Evans S, Ling M, Hill B, Rinehart N, Austin D, Sciberras E. Systematic review of meditation-based interventions for children with ADHD. Eur Child Adolesc Psychiatry. 2018;27(1):9–27.

    PubMed  Google Scholar 

  37. Shier AC, Reichenbacher T, Ghuman HS, Ghuman JK. Pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: clinical strategies. J Cent Nerv Syst Dis. 2012;5:1–17.

    PubMed  PubMed Central  Google Scholar 

  38. Lerner M, Wigal T. Long-term safety of stimulant medications used to treat children with ADHD. Pediatr Ann. 2008;37(1):37–45.

    PubMed  Google Scholar 

  39. Kooij SJ, Bejerot S, Blackwell A, et al. European consensus statement on diagnosis and treatment of adult ADHD: the European Network Adult ADHD. BMC Psychiatry. 2010;10:67.

    PubMed  PubMed Central  Google Scholar 

  40. Cooper RE, Williams E, Seegobin S, Tye C, Kuntsi J, Asherson P. Cannabinoids in attention-deficit/hyperactivity disorder: a randomised-controlled trial. Eur Neuropsychopharmacol. 2017;27(8):795–808.

    PubMed  Google Scholar 

  41. Pujalte GGA, Maynard JR, Thurston MJ, Taylor WC 3rd, Chauhan M. Considerations in the care of athletes with attention deficit hyperactivity disorder. Clin J Sport Med. 2019;29(3):245–56.

    PubMed  Google Scholar 

  42. Parr JW. Attention-deficit hyperactivity disorder and the athlete: new advances and understanding. Clin Sports Med. 2011;30(3):591–610.

    PubMed  Google Scholar 

  43. Nazeer A, Mansour M, Gross KA. ADHD and adolescent athletes. Front Public Health. 2014;2:46.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Excelsior Orthopaedics, Buffalo, NY, USA

    Jason M. Matuszak

  2. University at Buffalo, School of Medicine, Buffalo, NY, USA

    Jason M. Matuszak

Authors
  1. Jason M. Matuszak
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Family Medicine and Department of Orthopaedics, Medical University of South Carolina, Charleston, SC, USA

    Eugene Hong

  2. Department of Family Medicine, University of Washington, Seattle, WA, USA

    Ashwin L. Rao

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Matuszak, J.M. (2020). Attention Deficit/Hyperactivity Disorder (ADHD). In: Hong, E., Rao, A. (eds) Mental Health in the Athlete. Springer, Cham. https://doi.org/10.1007/978-3-030-44754-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-44754-0_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-44753-3

  • Online ISBN: 978-3-030-44754-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation